• Explore /
  • Poster
  • / Cabozantinib (C) in combination with atezolizumab (A) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results of Cohort 6 of the COSMIC-021 Study.

Cabozantinib (C) in combination with atezolizumab (A) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results of Cohort 6 of the COSMIC-021 Study.

Abstract Poster

Authors

Neeraj Agarwal

Neeraj Agarwal

Internal Medicine, Huntsman Cancer Institute, Salt Lake City, UT

Neeraj Agarwal , Yohann Loriot , Bradley Alexander McGregor , Robert Dreicer , Tanya B. Dorff , Benjamin Louis Maughan , William Kevin Kelly , Lance C. Pagliaro , Sandy Srinivas , Christian Michael Squillante , Ulka N. Vaishampayan , Yingjie Liu , Dominic Curran , Toni K. Choueiri , Sumanta K. Pal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03170960

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 139)

Abstract #

139

Poster Bd #

F19

Abstract Disclosures

Similar Posters

First Author: Neeraj Agarwal

First Author: Neeraj Agarwal

First Author: Srikala S. Sridhar

First Author: Henry Jacob Conter